These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15992178)

  • 1. GABA signalling: therapeutic targets for epilepsy, Parkinson's disease and Huntington's disease.
    Kleppner SR; Tobin AJ
    Expert Opin Ther Targets; 2001 Apr; 5(2):219-39. PubMed ID: 15992178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into GABA
    Hsu YT; Chang YG; Chern Y
    Open Biol; 2018 Dec; 8(12):. PubMed ID: 30518638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel synthesis and release of GABA in cerebellar granule cell cultures after infection with defective herpes simplex virus vectors expressing glutamic acid decarboxylase.
    New KC; Gale K; Martuza RL; Rabkin SD
    Brain Res Mol Brain Res; 1998 Oct; 61(1-2):121-35. PubMed ID: 9795182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role of GABA analogues in the treatment of neurological diseases.
    Gajcy K; Lochyński S; Librowski T
    Curr Med Chem; 2010; 17(22):2338-47. PubMed ID: 20491640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are vesicular neurotransmitter transporters potential treatment targets for temporal lobe epilepsy?
    Van Liefferinge J; Massie A; Portelli J; Di Giovanni G; Smolders I
    Front Cell Neurosci; 2013 Aug; 7():139. PubMed ID: 24009559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurochemical and neuropharmacological indications for the involvement of GABA and glycine receptors in neuropsychiatric disorders.
    Lloyd KG; DeMontis G; Broekkamp CL; Thuret F; Worms P
    Adv Biochem Psychopharmacol; 1983; 37():137-48. PubMed ID: 6138947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intervention of GABAergic neurotransmission in partial epilepsies].
    Bureau M; Laschet J; Minier F; Chauvel P
    Rev Neurol (Paris); 1997; 153 Suppl 1():S46-54. PubMed ID: 9686248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insight Into the Emerging Role of Striatal Neurotransmitters in the Pathophysiology of Parkinson's Disease and Huntington's Disease: A Review.
    Jamwal S; Kumar P
    Curr Neuropharmacol; 2019; 17(2):165-175. PubMed ID: 29512464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased GABAergic function in mouse models of Huntington's disease: reversal by BDNF.
    Cepeda C; Starling AJ; Wu N; Nguyen OK; Uzgil B; Soda T; André VM; Ariano MA; Levine MS
    J Neurosci Res; 2004 Dec; 78(6):855-67. PubMed ID: 15505789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of zonisamide on molecular regulation of glutamate and GABA transporter proteins during epileptogenesis in rats with hippocampal seizures.
    Ueda Y; Doi T; Tokumaru J; Willmore LJ
    Brain Res Mol Brain Res; 2003 Aug; 116(1-2):1-6. PubMed ID: 12941455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational approaches for the design of various GABA modulators and their clinical progression.
    Bhagat K; Singh JV; Pagare PP; Kumar N; Sharma A; Kaur G; Kinarivala N; Gandu S; Singh H; Sharma S; Bedi PMS
    Mol Divers; 2021 Feb; 25(1):551-601. PubMed ID: 32170466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered behavioral responses to gamma-aminobutyric acid pharmacological agents in a mouse model of Huntington's disease.
    Hsu YT; Chang YG; Chang CP; Siew JJ; Chen HM; Tsai CH; Chern Y
    Mov Disord; 2017 Nov; 32(11):1600-1609. PubMed ID: 28782830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of malonate-induced GABA but not dopamine loss by GABA transporter blockade in rat striatum.
    Zeevalk GD; Manzino L; Sonsalla PK
    Exp Neurol; 2002 Jul; 176(1):193-202. PubMed ID: 12093096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of GABA.
    Meldrum B
    Clin Neuropharmacol; 1982; 5(3):293-316. PubMed ID: 6214305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diversity of GABA(A) receptor subunit distribution in the normal and Huntington's disease human brain.
    Waldvogel HJ; Faull RL
    Adv Pharmacol; 2015; 73():223-64. PubMed ID: 25637443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tonic GABA inhibition in hippocampal dentate granule cells: its regulation and function in temporal lobe epilepsies.
    Li ZX; Yu HM; Jiang KW
    Acta Physiol (Oxf); 2013 Nov; 209(3):199-211. PubMed ID: 23865761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of constitutive functional γ-aminobutyric acid type A-B receptor crosstalk in layer 5 pyramidal neurons of human epileptic temporal cortex.
    Martinello K; Sciaccaluga M; Morace R; Mascia A; Arcella A; Esposito V; Fucile S
    Epilepsia; 2018 Feb; 59(2):449-459. PubMed ID: 29283181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unique pH dynamics in GABAergic synaptic vesicles illuminates the mechanism and kinetics of GABA loading.
    Egashira Y; Takase M; Watanabe S; Ishida J; Fukamizu A; Kaneko R; Yanagawa Y; Takamori S
    Proc Natl Acad Sci U S A; 2016 Sep; 113(38):10702-7. PubMed ID: 27601664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino acid neurotransmitter abnormalities in Huntington's disease and the quinolinic acid animal model of Huntington's disease.
    Ellison DW; Beal MF; Mazurek MF; Malloy JR; Bird ED; Martin JB
    Brain; 1987 Dec; 110 ( Pt 6)():1657-73. PubMed ID: 2892568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.